Your search returned 3 results.

Results
	1.	Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1). [electronic resource] by Zemmrich, Claudia Lüders, Stephan Gansz, Andrea Sturm, Claus-Dieter Fimmers, Rolf Nadal, Jennifer Schmieder, Roland E Schrader, Joachim Bramlage, Peter Producer: 20160429 In: Journal of clinical hypertension (Greenwich, Conn.) vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Daytime systolic ambulatory blood pressure with a two-step switch from candesartan to olmesartan monotherapy and the fixed-dose combination of olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-2). [electronic resource] by Bramlage, Peter Zemmrich, Claudia Gansz, Andrea Sturm, Claus-Dieter Fimmers, Rolf Nadal, Jennifer Schmieder, Roland E Schrader, Joachim Lüders, Stephan Producer: 20140930 In: Journal of clinical hypertension (Greenwich, Conn.) vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. [electronic resource] by Lüders, Stephan Schrader, Joachim Berger, Jürgen Unger, Thomas Zidek, Walter Böhm, Michael Middeke, Martin Motz, Wolfgang Lübcke, Cornelia Gansz, Andrea Brokamp, Ludmer Schmieder, Roland E Trenkwalder, Peter Haller, Herrmann Dominiak, Peter Producer: 20081023 In: Journal of hypertension vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)